辅助生殖技术后低β-hCG早期妊娠中M4模型预测异位妊娠的性能
前瞻性队列研究纳入243例辅助生殖技术受孕、孕4+0至4+2周β-hCG 5-50 IU/L的早期妊娠,按M4模型分为高危(疑似异位妊娠/持续性不明位置妊娠)和低危。以孕11-13周最终结局为参考,M4模型检测高危妊娠的敏感度60.0%、特异度79.8%,AUC 0.72,模型分类与最终诊断一致性低(kappa 0.30),作者不推荐在该类妊娠中使用M4模型。
要点
- M4模型在ART后低β-hCG早期妊娠中鉴别高危(EP/PPUL)的AUC仅0.72,分类一致性低(kappa 0.30)。
- 14例最终高危妊娠被M4初始判为低危,其中2例需腹腔镜手术,但无严重不良事件。
- 该人群仅19.3%最终为宫内妊娠,其中半数早期流产,持续妊娠率仅9.5%。
诊断标准与关键数值
- M4模型高危(疑似EP/PPUL)定义为异位妊娠风险≥5%,低危定义为风险<5%且根据IUP与FPUL似然比进一步分为疑似IUP或疑似FPUL。
- M4模型检测高危妊娠(EP/PPUL)的敏感度60.0%(95%CI 43.6-74.4%),特异度79.8%(95%CI 73.8-84.7%)。
- M4模型鉴别高危与低危(FPUL/IUP)妊娠的AUC为0.72(95%CI 0.62-0.81),阳性似然比2.97(95%CI 2.03-4.36),阴性似然比0.50(95%CI 0.33-0.76)。
- 模型分类与最终诊断的kappa指数为0.30(95%CI 0.16-0.43),一致性低。
临床应用与阅片要点
- 对ART受孕、孕4周左右β-hCG 5-50 IU/L的妊娠,M4模型分类与最终诊断一致性低,阅片和报告中应结合系列β-hCG和超声随访综合判断。
- 模型判为低危者仍可能最终为EP/PPUL(本研究14例),随访中需警惕。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the safety and performance of the M4 model for classifying as high risk or low risk for ectopic pregnancy (EP) pregnancies conceived by assisted reproductive technologies (ART) that present with low beta-human chorionic gonadotropin (β-hCG) concentration in early gestation.
METHODS: This was a prospective cohort study of 243 pregnancies conceived by ART with low β-hCG levels (5-50 IU/L) at 4 + 0 to 4 + 2 weeks' gestation. After subsequent β-hCG testing at 48 h, pregnancies were classified according to the M4 model into the following categories: (i) high risk, probable EP/persistent pregnancy of unknown location (PPUL), when the risk for EP was ≥ 5%; (ii) low risk, probable intrauterine pregnancy (IUP), when the risk of EP was < 5% and the likelihood of IUP was greater than that of a failed pregnancy of unknown location (FPUL); and (iii) low risk, probable FPUL, when the risk of EP was < 5% and the likelihood of a FPUL was greater than that of an IUP. The predictive performance of the M4 model for EP and its ability to discriminate between high- and low-risk pregnancies was assessed using the final pregnancy outcome at 11 to 13 weeks of gestation as reference, which was classified as EP/PPUL, FPUL or IUP.
RESULTS: The sensitivity and specificity of the M4 model in detecting a high-risk pregnancy (EP/PPUL) were 60.0% (95% CI, 43.6-74.4%) and 79.8% (95% CI, 73.8-84.7%), respectively. The area under the receiver-operating-characteristics curve of the M4 model for discriminating between high-risk and low-risk (FPUL/IUI) pregnancies was 0.72 (95% CI, 0.62-0.81). The model had a positive likelihood ratio of 2.97 (95% CI, 2.03-4.36) and a negative likelihood ratio of 0.50 (95% CI, 0.33-0.76). The kappa index was 0.30 (95% CI, 0.16-0.43), indicating a low degree of agreement between the model classification and the final diagnosis. No serious adverse events related directly to the application of the M4 model were observed, although 14 pregnancies classified ultimately as high risk had been categorized initially as low risk by the M4 model. Of these, seven resolved with expectant management, five with methotrexate (MTX) and two required laparoscopic surgery (one after failure of medical treatment with MTX and one after deviation from the follow-up protocol). There were no cases of EP/PPUL with additional complications or need for blood or other blood product transfusion. Of the 243 ART pregnancies with low β-hCG concentration in early gestation, only 47 (19.3%) had an IUP, half (24/47) of which had an early miscarriage, resulting in only 9.5% (23/243) cases having an ongoing pregnancy.
CONCLUSIONS: Application of the M4 model in pregnancies conceived by ART with low β-hCG concentration in early gestation showed limited capacity in classifying them as being at low or high risk for EP, therefore, its use in pregnancies of this type is not recommended. No serious adverse events or complications related to the use of the model were observed. These pregnancies have a low probability of ending in an IUP as well as a high rate of early miscarriage. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Valdera Simbrón CJ, Hernández Rodríguez C, Llanos Jiménez L, et al. Management of early gestations with low beta-human chorionic gonadotropin conceived by assisted reproductive technologies: performance of M4 predictive model. Ultrasound Obstet Gynecol. 2021. PMID: 33656199. doi:10.1002/uog.23625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。